Cipla Limited Share Price & Analysis
₹1,402Updated 5 Jun 2026, 03:30 pm IST
LTP
₹1,402
—
Open
₹1,394
High
₹1,406.1
Low
₹1,382
Close
₹1,398.7
52W High
₹1,673
52W Low
₹1,166
Volume
1050K
Lot Size
375
Sector
Healthcare
Market Cap
₹1.1L Cr
Face Value
₹2
Large CapNIFTY 100NIFTY 200NIFTY 50NIFTY 500
Price Chart
Fundamentals
P/E
27.3
Sector P/E
48.9
P/B
3.29
EPS
₹56.29
ROE
12.4%
ROCE
16.6%
D/E Ratio
0.02
Div Yield
0.94%
Book Value
₹426
+
Strengths
- ✓Efficient capital deployment (ROCE 16.6%)
- ✓Attractively valued vs sector (P/E 27.3x vs industry 48.9x)
- ✓Virtually debt-free
Peer Comparison
| Company | CMP | Mkt Cap | P/E | P/B | ROE % | ROCE % | D/E |
|---|---|---|---|---|---|---|---|
| SUNPHARMA Sun Pharmaceutical Industries Limited | ₹1,783 | ₹4.3L Cr | 34.4 | 5.12 | 16 | 20.5 | 0.07 |
| DIVISLAB Divi's Laboratories Limited | ₹6,616 | ₹1.7L Cr | 66.1 | 10.48 | 16.5 | 22 | 0.01 |
| TORNTPHARM Torrent Pharmaceuticals Limited | ₹4,416 | ₹1.5L Cr | 66.4 | 17.81 | 27.6 | 15.4 | 0.33 |
| APOLLOHOSP Apollo Hospitals Enterprise Limited | ₹8,315 | ₹1.2L Cr | 59.5 | 12.62 | 22.1 | 17.9 | 0.88 |
| ZYDUSLIFE Zydus Lifesciences Limited | ₹1,091 | ₹1.1L Cr | 20 | 4.05 | 21.2 | 21.2 | 0.38 |
| DRREDDY Dr. Reddy's Laboratories Limited | ₹1,283 | ₹1.1L Cr | 25.4 | 2.83 | 11.8 | 13.6 | 0.16 |
| LUPIN Lupin Limited | ₹2,260 | ₹1.0L Cr | 17.9 | 4.6 | 29.1 | 30.3 | 0.32 |
Showing 7 peers in the same sector · Sorted by market cap
Shareholding Pattern
CIPLA · as of Mar 2026
Promoters29.20%
FII26.28%▼0.37
DII27.89%▲0.40
Public16.36%▼0.07
Govt0.26%▲0.03
| Category | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|
| Promoters | 33.46% | 33.46% | 30.91% | 30.93% | 29.19% | 29.20% |
| FII | 25.73% | 25.82% | 27.82% | 28.80% | 26.65% | 26.28% |
| DII | 24.05% | 24.15% | 24.66% | 23.95% | 27.49% | 27.89% |
| Public | 16.53% | 16.36% | 16.40% | 16.11% | 16.43% | 16.36% |
| Govt | 0.21% | 0.21% | 0.21% | 0.21% | 0.23% | 0.26% |
Corporate Events
Dividend - Rs 13 Per Share
Dividend4 Jun 2026
To consider and approve the financial results for the period ended March 31, 2026, dividend and other business matters
Dividend12 May 2026
Dividend - Rs 13 Per Share/Special Dividend - Rs 3 Per Share
Dividend26 Jun 2025
Dividend - Rs 13 Per Share
Dividend1 Aug 2024
Dividend - Rs 8.50 Per Share
Dividend20 Jul 2023
Financials
Quarterly Results
| Metric | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | ₹7.1K Cr ▼6.8% | ₹7.6K Cr ▲9.1% | ₹7.0K Cr ▲3.4% | ₹6.7K Cr ▼4.8% | ₹7.1K Cr ▲0.3% | ₹7.1K Cr ▲5.3% | ₹6.7K Cr ▲8.6% | ₹6.2K Cr |
| Op. Profit | ₹1.3K Cr ▼33.8% | ₹1.9K Cr ▲6.6% | ₹1.8K Cr ▲15.6% | ₹1.5K Cr ▼22.7% | ₹2.0K Cr ▲5.5% | ₹1.9K Cr ▲9.9% | ₹1.7K Cr ▲30.4% | ₹1.3K Cr |
| OPM | 18.0% ▼28.0% | 25.0% ▼3.8% | 26.0% ▲13.0% | 23.0% ▼17.9% | 28.0% ▲3.7% | 27.0% ▲3.8% | 26.0% ▲23.8% | 21.0% |
| Net Profit | ₹674 Cr ▼50.2% | ₹1.4K Cr ▲4.7% | ₹1.3K Cr ▲6.4% | ₹1.2K Cr ▼22.9% | ₹1.6K Cr ▲20.7% | ₹1.3K Cr ▲11.1% | ₹1.2K Cr ▲26.1% | ₹932 Cr |
| EPS (₹) | 8.37 ▼50.0% | 16.73 ▲4.2% | 16.06 ▲6.1% | 15.13 ▼22.2% | 19.45 ▲20.6% | 16.13 ▲10.6% | 14.58 ▲25.4% | 11.63 |
Values in ₹ Cr · Source: Screener.in
Annual Profit & Loss
| Metric | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 | Mar 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | ₹28.2K Cr ▲2.2% | ₹27.5K Cr ▲6.9% | ₹25.8K Cr ▲13.3% | ₹22.8K Cr ▲4.5% | ₹21.8K Cr ▲13.6% | ₹19.2K Cr ▲11.8% | ₹17.1K Cr ▲4.7% | ₹16.4K Cr ▲8.0% | ₹15.2K Cr ▲5.3% | ₹14.4K Cr |
| Expenses | ₹22.3K Cr ▲9.1% | ₹20.4K Cr ▲4.8% | ₹19.5K Cr ▲9.9% | ₹17.7K Cr ▲3.0% | ₹17.2K Cr ▲15.5% | ₹14.9K Cr ▲7.0% | ₹13.9K Cr ▲5.0% | ₹13.3K Cr ▲7.6% | ₹12.3K Cr ▲3.6% | ₹11.9K Cr |
| Op. Profit | ₹5.9K Cr ▼17.5% | ₹7.1K Cr ▲13.3% | ₹6.3K Cr ▲25.1% | ₹5.0K Cr ▲10.4% | ₹4.6K Cr ▲7.1% | ₹4.3K Cr ▲32.6% | ₹3.2K Cr ▲3.5% | ₹3.1K Cr ▲9.6% | ₹2.8K Cr ▲13.2% | ₹2.5K Cr |
| OPM | 21.0% ▼19.2% | 26.0% ▲8.3% | 24.0% ▲9.1% | 22.0% ▲4.8% | 21.0% ▼4.5% | 22.0% ▲15.8% | 19.0% ▲0.0% | 19.0% ▲0.0% | 19.0% ▲11.8% | 17.0% |
| Other Income | ₹606 Cr ▼29.7% | ₹862 Cr ▲56.2% | ₹552 Cr ▲88.4% | ₹293 Cr ▲196.0% | ₹99 Cr ▼62.8% | ₹266 Cr ▼22.7% | ₹344 Cr ▼27.9% | ₹477 Cr ▲70.4% | ₹280 Cr ▲34.6% | ₹208 Cr |
| Interest | ₹54 Cr ▼12.9% | ₹62 Cr ▼31.1% | ₹90 Cr ▼18.2% | ₹110 Cr ▲3.8% | ₹106 Cr ▼34.2% | ₹161 Cr ▼18.3% | ₹197 Cr ▲17.3% | ₹168 Cr ▲47.4% | ₹114 Cr ▼28.3% | ₹159 Cr |
| Depreciation | ₹1.2K Cr ▲9.4% | ₹1.1K Cr ▲5.3% | ₹1.1K Cr ▼10.3% | ₹1.2K Cr ▲11.4% | ₹1.1K Cr ▼1.5% | ₹1.1K Cr ▼9.1% | ₹1.2K Cr ▼11.4% | ₹1.3K Cr ▲0.2% | ₹1.3K Cr ▲0.0% | ₹1.3K Cr |
| PBT | ₹5.2K Cr ▼23.4% | ₹6.8K Cr ▲19.6% | ₹5.7K Cr ▲41.2% | ₹4.0K Cr ▲15.6% | ₹3.5K Cr ▲6.2% | ₹3.3K Cr ▲51.1% | ₹2.2K Cr ▲4.8% | ₹2.1K Cr ▲24.6% | ₹1.7K Cr ▲36.6% | ₹1.2K Cr |
| Tax % | 26.0% ▲18.2% | 22.0% ▼18.5% | 27.0% ▼10.0% | 30.0% ▲11.1% | 27.0% ▲0.0% | 27.0% ▼6.9% | 29.0% ▲7.4% | 27.0% ▲80.0% | 15.0% ▲0.0% | 15.0% |
| Net Profit | ₹3.9K Cr ▼26.7% | ₹5.3K Cr ▲26.8% | ₹4.2K Cr ▲46.6% | ₹2.8K Cr ▲11.2% | ₹2.5K Cr ▲6.6% | ₹2.4K Cr ▲59.3% | ₹1.5K Cr ▲0.5% | ₹1.5K Cr ▲5.3% | ₹1.4K Cr ▲36.9% | ₹1.0K Cr |
| EPS (₹) | 48.02 ▼26.4% | 65.28 ▲27.9% | 51.05 ▲47.1% | 34.71 ▲11.3% | 31.19 ▲4.6% | 29.82 ▲55.5% | 19.18 ▲1.2% | 18.96 ▲8.2% | 17.52 ▲40.0% | 12.51 |
| Div Payout | 27.0% ▲8.0% | 25.0% ▲0.0% | 25.0% ▲4.2% | 24.0% ▲50.0% | 16.0% ▼5.9% | 17.0% ▼19.0% | 21.0% ▲31.3% | 16.0% ▼5.9% | 17.0% ▲6.3% | 16.0% |
Values in ₹ Cr · Source: Screener.in
Balance Sheet
| Item | Sep 2025 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 | Mar 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Liabilities | ||||||||||
| Equity Capital | ₹162 Cr ▲0.0% | ₹162 Cr ▲0.6% | ₹161 Cr ▲0.0% | ₹161 Cr ▲0.0% | ₹161 Cr ▲0.0% | ₹161 Cr ▲0.0% | ₹161 Cr ▲0.0% | ₹161 Cr ▲0.0% | ₹161 Cr ▲0.0% | ₹161 Cr |
| Reserves | ₹32.8K Cr ▲5.6% | ₹31.0K Cr ▲16.9% | ₹26.5K Cr ▲14.2% | ₹23.2K Cr ▲12.4% | ₹20.7K Cr ▲13.8% | ₹18.2K Cr ▲16.4% | ₹15.6K Cr ▲5.1% | ₹14.9K Cr ▲5.6% | ₹14.1K Cr ▲13.6% | ₹12.4K Cr |
| Borrowings | ₹467 Cr ▲6.6% | ₹438 Cr ▼21.6% | ₹559 Cr ▼30.4% | ₹803 Cr ▼24.0% | ₹1.1K Cr ▼47.6% | ₹2.0K Cr ▼28.5% | ₹2.8K Cr ▼34.8% | ₹4.3K Cr ▲5.3% | ₹4.1K Cr ▼0.4% | ₹4.1K Cr |
| Other Liabilities | ₹6.8K Cr ▲18.9% | ₹5.7K Cr ▲8.3% | ₹5.3K Cr ▲3.5% | ₹5.1K Cr ▲2.6% | ₹5.0K Cr ▲9.9% | ₹4.5K Cr ▼6.8% | ₹4.8K Cr ▲9.2% | ₹4.4K Cr ▲2.0% | ₹4.3K Cr ▲3.2% | ₹4.2K Cr |
| Total Liabilities | ₹40.2K Cr ▲7.6% | ₹37.3K Cr ▲14.8% | ₹32.5K Cr ▲11.0% | ₹29.3K Cr ▲9.1% | ₹26.9K Cr ▲8.1% | ₹24.9K Cr ▲6.1% | ₹23.4K Cr ▼1.4% | ₹23.8K Cr ▲4.8% | ₹22.7K Cr ▲8.6% | ₹20.9K Cr |
| Assets | ||||||||||
| Fixed Assets | ₹10.9K Cr ▲9.3% | ₹10.0K Cr ▲4.2% | ₹9.6K Cr ▲4.9% | ₹9.2K Cr ▼5.4% | ₹9.7K Cr ▲1.8% | ₹9.5K Cr ▼1.7% | ₹9.7K Cr ▲0.8% | ₹9.6K Cr ▼3.4% | ₹9.9K Cr ▲4.8% | ₹9.5K Cr |
| CWIP | ₹1.4K Cr ▼8.2% | ₹1.6K Cr ▲35.8% | ₹1.2K Cr ▲5.5% | ₹1.1K Cr ▲42.7% | ₹766 Cr ▼20.9% | ₹969 Cr ▲17.5% | ₹825 Cr ▲22.0% | ₹676 Cr ▼31.1% | ₹981 Cr ▼41.7% | ₹1.7K Cr |
| Investments | ₹8.2K Cr ▲3.6% | ₹7.9K Cr ▲45.6% | ₹5.4K Cr ▲48.8% | ₹3.7K Cr ▲43.6% | ₹2.6K Cr ▼5.9% | ₹2.7K Cr ▲84.2% | ₹1.5K Cr ▼42.4% | ₹2.6K Cr ▲102.9% | ₹1.3K Cr ▲29.4% | ₹973 Cr |
| Other Assets | ₹19.6K Cr ▲9.8% | ₹17.8K Cr ▲9.2% | ₹16.3K Cr ▲6.1% | ₹15.4K Cr ▲11.0% | ₹13.9K Cr ▲18.8% | ₹11.7K Cr ▲1.9% | ₹11.4K Cr ▲4.8% | ₹10.9K Cr ▲4.2% | ₹10.5K Cr ▲20.2% | ₹8.7K Cr |
| Total Assets | ₹40.2K Cr ▲7.6% | ₹37.3K Cr ▲14.8% | ₹32.5K Cr ▲11.0% | ₹29.3K Cr ▲9.1% | ₹26.9K Cr ▲8.1% | ₹24.9K Cr ▲6.1% | ₹23.4K Cr ▼1.4% | ₹23.8K Cr ▲4.8% | ₹22.7K Cr ▲8.6% | ₹20.9K Cr |
Values in ₹ Cr · Source: Screener.in
Cash Flow Statement
| Item | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 | Mar 2017 | Mar 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating CF | ₹5.0K Cr ▲21.1% | ₹4.1K Cr ▲27.7% | ₹3.2K Cr ▼2.6% | ₹3.3K Cr ▼11.4% | ₹3.8K Cr ▲22.4% | ₹3.1K Cr ▲81.4% | ₹1.7K Cr ▲15.6% | ₹1.5K Cr ▼38.6% | ₹2.4K Cr ▲36.8% | ₹1.7K Cr |
| Investing CF | ₹-3.7K Cr ▼23.5% | ₹-3.0K Cr ▼25.5% | ₹-2.4K Cr ▼27.9% | ₹-1.9K Cr ▲21.7% | ₹-2.4K Cr ▼2182.5% | ₹114 Cr ▲106.8% | ₹-1.7K Cr ▼102.4% | ₹-834 Cr ▲36.0% | ₹-1.3K Cr ▲71.2% | ₹-4.5K Cr |
| Financing CF | ₹-1.3K Cr ▼7.8% | ₹-1.2K Cr ▼25.3% | ₹-958 Cr ▲40.1% | ₹-1.6K Cr ▼29.0% | ₹-1.2K Cr ▲58.0% | ₹-2.9K Cr ▼745.0% | ₹-349 Cr ▲9.4% | ₹-385 Cr ▲71.0% | ₹-1.3K Cr ▼142.7% | ₹3.1K Cr |
| Net Cash Flow | ₹30 Cr ▲161.2% | ₹-49 Cr ▲49.5% | ₹-97 Cr ▲26.5% | ₹-132 Cr ▼193.6% | ₹141 Cr ▼39.7% | ₹234 Cr ▲167.8% | ₹-345 Cr ▼242.0% | ₹243 Cr ▲198.0% | ₹-248 Cr ▼179.5% | ₹312 Cr |
| Free Cash Flow | ₹3.5K Cr ▲23.8% | ₹2.8K Cr ▲34.1% | ₹2.1K Cr ▼20.5% | ₹2.6K Cr ▼10.8% | ₹3.0K Cr ▲42.3% | ₹2.1K Cr ▲75.5% | ₹1.2K Cr ▲64.2% | ₹723 Cr ▼43.7% | ₹1.3K Cr ▲86.6% | ₹688 Cr |
Values in ₹ Cr · Source: Screener.in
Key Ratios History
| Metric | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 | Mar 2017 | Mar 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 73d ▲7.4% | 68d ▲4.6% | 65d ▲14.0% | 57d ▼13.6% | 66d ▼20.5% | 83d ▼10.8% | 93d ▲24.0% | 75d ▲15.4% | 65d ▲4.8% | 62d |
| Inventory Days | 231d ▲6.5% | 217d ▼4.8% | 228d ▼0.9% | 230d ▼0.9% | 232d ▼13.1% | 267d ▲6.8% | 250d ▼7.7% | 271d ▲13.4% | 239d ▼12.5% | 273d |
| Days Payable | 116d ▲13.7% | 102d ▼8.9% | 112d ▲3.7% | 108d ▲4.9% | 103d ▼25.9% | 139d ▲13.0% | 123d ▼13.4% | 142d ▲31.5% | 108d ▲1.9% | 106d |
| Cash Conv. Cycle | 188d ▲3.3% | 182d ▲0.6% | 181d ▲0.6% | 180d ▼7.7% | 195d ▼7.6% | 211d ▼4.1% | 220d ▲7.8% | 204d ▲4.1% | 196d ▼14.8% | 230d |
| Working Capital Days | 128d ▲6.7% | 120d ▲6.2% | 113d ▲18.9% | 95d ▲1.1% | 94d ▼16.8% | 113d ▼14.4% | 132d ▲11.9% | 118d ▲19.2% | 99d ▲1090.0% | -10d |
| ROCE | 23.0% ▲0.0% | 23.0% ▲27.8% | 18.0% ▲5.9% | 17.0% ▲0.0% | 17.0% ▲41.7% | 12.0% ▲9.1% | 11.0% ▲22.2% | 9.0% ▲28.6% | 7.0% ▼46.2% | 13.0% |
Source: Screener.in · Lower days = better efficiency
Deep Dive Analysis
About Cipla Limited
Incorporated in 1935, Cipla Ltd is in the business of manufacturing, developing, and marketing a wide range of branded and generic formulations and APIs[1]
Healthcare · Pharmaceuticals & Biotechnology
Related Analysis
Frequently Asked Questions
What is Cipla Limited share price today?▾
Cipla Limited (CIPLA) is currently trading at ₹1,402 on NSE, as of the last market session. Prices update daily after market close on MarketNetra.
Is Cipla Limited available in F&O (Futures & Options)?▾
Yes, Cipla Limited (CIPLA) is part of the NSE F&O segment with a lot size of 375 shares. Options are available with monthly expiry contracts. You can track the full option chain and OI analysis on MarketNetra.
What is Cipla Limited 52-week high and low?▾
Cipla Limited's 52-week high is ₹1,673 and the 52-week low is ₹1,166. The current price of ₹1,402 is 16.2% below the 52W high.
What is Cipla Limited P/E ratio?▾
Cipla Limited's current P/E ratio is 27.3. This indicates the market is paying ₹27.3 for every ₹1 of earnings. Compare this to the sector average to assess relative valuation.
How to trade Cipla Limited options?▾
Cipla Limited options are traded on NSE with monthly expiry contracts (lot size: 375 shares). To trade CIPLA options: select your expiry on the option chain page, identify key OI strikes, check the PCR and buildup type on OI analysis, and review FII/DII flows for institutional sentiment before taking a position.